← Back to Search

Behavioral Intervention

Online Intervention for HIV/AIDS (ORCHID-Miami Trial)

N/A
Recruiting
Led By Lunthita M Duthely, Ed.D.
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a skills-building intervention to help HIV+ people stay in care & improve their mental health.

Who is the study for?
The ORCHID trial is for adult women with HIV who are treated at the University of Miami Women's HIV Service. They must have had HPV or related health issues in the past year and may struggle with substance use or mental health conditions like depression, anxiety, or PTSD. Participants should not be cognitively impaired, imprisoned, under 18, unable to read/write English at a basic level, or have severe psychiatric disorders.
What is being tested?
ORCHID is an online program designed to help improve mental well-being in women living with HIV. It focuses on building skills to cope better and stay engaged in their healthcare. The study will evaluate how effective this intervention is for those who might be at risk of dropping out of care due to various challenges.
What are the potential side effects?
Since ORCHID is a non-medical online intervention focusing on resilience and coping strategies rather than medication or physical treatments, it does not have traditional side effects associated with drugs or medical procedures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Proportion of Participants who Complete ORCHID
Secondary study objectives
Depression as measured by Patient Health Questionnaire (PHQ-9)
Positive Affect as measured by Positive and Negative Affect Schedule (PANAS)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: ORCHID GroupExperimental Treatment1 Intervention
Participants in the ORCHID group will receive an online intervention that improves depressive symptoms and positive affect (emotions) for clinic-based persons living with HIV, for up to 6 months.

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor
955 Previous Clinical Trials
428,823 Total Patients Enrolled
Northwestern UniversityOTHER
1,652 Previous Clinical Trials
961,485 Total Patients Enrolled
Lunthita M Duthely, Ed.D.Principal InvestigatorUniversity of Miami
1 Previous Clinical Trials
80 Total Patients Enrolled

Media Library

ORCHID (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05935644 — N/A
HIV/AIDS Research Study Groups: ORCHID Group
HIV/AIDS Clinical Trial 2023: ORCHID Highlights & Side Effects. Trial Name: NCT05935644 — N/A
ORCHID (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05935644 — N/A
~15 spots leftby Feb 2025